APLLTD Share Price Performance
₹0
-851.95 (-100.00%)
Price ₹0
Fair Value₹845.00
Share Pricen/a
Alembic Pharmaceuticals Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 7 Fair Values set on narratives written by author
APLLTD Community Narratives
AN
Fair Value ₹845 11.4% undervalued intrinsic discount
Regulatory Scrutiny And Supply Issues Will Squeeze Pharma Prospects
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value ₹949.9 21.2% undervalued intrinsic discount
US Product Launches And India Execution Will Expand Reach
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
Fair Value ₹1.28k 41.3% undervalued intrinsic discount
Aging Populations And Emerging Markets Will Transform Pharmaceutical Opportunities
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
US Product Launches And India Execution Will Expand Reach
Key Takeaways Focus on execution, new launches, and operational efficiency aims to drive growth and margin expansion across India, US, and global markets. Strategic R&D investment in complex generics and specialty drugs positions Alembic for higher-margin opportunities and sustainable long-term earnings.Read more
30
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
₹949.9
21.2% undervalued intrinsic discount
Fair Value
Revenue
10.18% p.a.
Profit Margin
11.92%
Future PE
22.99x
Price in 2029
₹1.35k
Regulatory Scrutiny And Supply Issues Will Squeeze Pharma Prospects
Key Takeaways Increased regulatory, compliance, and geopolitical pressures risk inflating costs, delaying launches, and destabilizing Alembic's overseas revenue streams. Heavy US market dependence and lag in biologics threaten market share, margins, and future earnings amid industry shifts and intensifying competition.Read more
7
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
₹845
11.4% undervalued intrinsic discount
Fair Value
Revenue
9.98% p.a.
Profit Margin
10.59%
Future PE
23.13x
Price in 2029
₹1.2k
Aging Populations And Emerging Markets Will Transform Pharmaceutical Opportunities
Key Takeaways Strong new product launches, pipeline scaling, and strategic focus on complex generics position Alembic for significant outperformance in revenue and earnings. Investments in specialized therapeutics and operational excellence enhance margin expansion and solidify market leadership amid industry consolidation.Read more
8
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
₹1.28k
41.3% undervalued intrinsic discount
Fair Value
Revenue
11.72% p.a.
Profit Margin
13.57%
Future PE
27.6x
Price in 2028
₹1.82k
Trending Discussion
Recently Updated Narratives
AN
APLLTD: US Approvals And First Branded Launch Will Support Upside Potential
Fair Value: ₹949.9 21.2% undervalued intrinsic discount
3 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
APLLTD: Expanding US Branded And Generic Portfolio Will Support Long Term Upside
Fair Value: ₹845 11.4% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Aging Populations And Emerging Markets Will Transform Pharmaceutical Opportunities
Fair Value: ₹1.28k 41.3% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Alembic Pharmaceuticals Limited Key Details
About APLLTD
- Founded
- 1907
- Employees
- 16571
- CEO
- WebsiteView website
Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.
